Laura van Why, MD
Dermatology · Fond du Lac, WINPI 1932132107
Payments from drug & device makers
Across 22 payments — averaging $36.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$203
- Regeneron Healthcare Solutions, Inc.$186
- LEO Pharma Inc.$88
- Novartis$74
- Galderma Laboratories, L.p.$53
- Boehringer Ingelheim$51
- plus $149 from 5 others
What the payments were for
- Food & beverage$71489%
- Education$9011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $203 |
| Regeneron Healthcare Solutions, Inc. | 7 | $186 |
| LEO Pharma Inc. | 2 | $88 |
| Novartis | 1 | $74 |
| Galderma Laboratories, L.p. | 1 | $53 |
| Boehringer Ingelheim | 1 | $51 |
| E.r. Squibb & Sons, L.L.C. | 1 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $42 |
| Organon | 3 | $27 |
| Lilly USA, LLC | 1 | $18 |
| Sanofi | 1 | $13 |
How this compares
$804 in reported general payments places this provider in the 60th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 235 | $9,632 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 52 | $2,683 |
| Fluorouracil | 34 | $2,562 |
| Doxycycline Monohydrate | 32 | $1,510 |
| Metronidazole | 19 | $1,347 |
| CiclopiroxCiclopirox Olamine | 52 | $1,023 |
| Ketoconazole | 64 | $984 |
| Ciclopirox | 32 | $939 |
| Triamcinolone Acetonide | 60 | $913 |
| Betamethasone Diprop AugmentedBetamethasone Dipropionate | 12 | $888 |
| Imiquimod | 27 | $506 |
| Clindamycin Phosphate | 17 | $453 |
| Hydrocortisone | 18 | $423 |
| Ammonium Lactate | 11 | $289 |
| Mometasone Furoate | 15 | $256 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fond du Lac
- Burt SteffesFond du Lac$4K
- Lisa ArkinMadison$1.4M
- David NelsenJanesville$1.1M
- Kenneth GordonWauwatosa$887K
- Gabriela MaloneyOconomowoc$725K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$247K
- Betsy WernliManitowoc$177K
- Clarence Brownla Crosse$152K
- Gretchen RothWauwatosa$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.